Boston-based Dana-Farber Cancer Institute has launched a cancer screening initiative for U.S. veterans. The program utilizes a multicancer early detection tool that screens for up to 50 cancers through a single blood test.
Military personnel have a 20% higher risk of developing cancer compared to the general population, according to a June 30 news release from the institute.
The initiative is part of the institute’s Sentinel clinical trial and will provide screening to 1,500 veterans over the age of 45. Participants must have served on active duty for eight or more years and have received care at a Veterans Administration facility within the past five years.
Dana-Farber physicians will oversee additional diagnostic workup for participants who receive positive screening results, the release said.
